🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase II, randomized, open-label, two-arm clinical trial evaluating the s...
Status
Suspended
Location
Alabama CRS
Start Date
2026-05-17
Trial ID
NCT06705478
Treatments Being Tested
The objectives of the studies are: * To demonstrate similar total exposure...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT02261103
The general aim of this study is to obtain long-term safety and tolerabilit...
Status
Completed
Location
248.633.01004 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00601523
Treatments Being Tested
The study compared pramipexole dihydrochloride extended-release tablets (Te...
Status
Completed
Location
The General Hospital of Western Theater Command PLA
Start Date
2017-03-16
Trial ID
NCT07519278
Bioequivalence between PPX ER 1.5 mg x 1 tablet q.d. and 0.375 mg PPX ER x ...
Status
Completed
Location
248.677.001 Boehringer Ingelheim Investigational Site
Start Date
2010-04
Trial ID
NCT01119443
The general aim of this study is to obtain long-term safety and tolerabilit...
Status
Completed
Location
248.634.43005 Boehringer Ingelheim Investigational Site
Start Date
2007-12
Trial ID
NCT00577460
Treatments Being Tested
The objectives of this study were to investigate relative BA at steady stat...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT02264132
Treatments Being Tested
The objective of the study is to assess that pramipexole does not prolong t...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT02262546
The objective of this trial is to investigate the safety, tolerability, tro...
Status
Completed
Location
248.610.019 Boehringer Ingelheim Investigational Site
Start Date
2007-11
Trial ID
NCT00560508
Treatments Being Tested
P2B001 is an investigational drug that comprised of low doses of two drugs,...
Status
Completed
Location
P2B001/003 Site Scottsdale
Start Date
2018-01-19
Trial ID
NCT03329508
Treatments Being Tested